Tradestie Institutional Equity Comparison Engine

ELVN vs MIRM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ELVN Overall Edge

ELVN Captures Institutional Edge (3โ€“0 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Enliven Therapeutics, Inc. Common Stock (ELVN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ELVN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus MIRM at N/M Forward P/E and -21.6% operating margin (+39.6% YoY). In options structure, ELVN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro) against MIRM sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ELVN N/M vs MIRM N/M Fwd P/E
Growth & Margin Winner ELVN
Op Margin 0.0% vs -21.6% ยท YoY +0.0% vs +39.6%
Momentum & Technical Winner ELVN
1Y +134.5% vs +34.2% ยท 52W Pos 69% vs 44%
Options & Structure Winner ELVN
CONSOLIDATION (5th %ile IV) vs BREAKDOWN (9th %ile IV)
ELVN NASDAQ
Enliven Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$47.54
-2.58% 1D
Market Cap $3.6B
1M Return +27.38%
1Y Return +134.53%
Forward P/E N/M
Unified AI Score
35.9 / 100 SELL
Tech 15.0 Fund 42.0 Flow 68.0 Mom 60.0
MIRM NASDAQ
Mirum Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$92.92
-1.14% 1D
Market Cap $6.1B
1M Return +15.94%
1Y Return +34.17%
Forward P/E N/M
Unified AI Score
38.1 / 100 SELL
Tech 8.0 Fund 37.0 Flow 71.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ELVN +134.53% MIRM +34.17% Spread: +100.36 pp (ELVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ELVN TTM Op. Margin: 0.0% MIRM TTM Op. Margin: -21.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ELVN vs MIRM. Trailing 12-month operating profitability (ELVN 0.0% vs MIRM -21.6%) and valuation multiples (ELVN N/M vs MIRM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ELVN (4) vs MIRM (4)
Institutional Metric ELVN MIRM Criterion Row Winner
Market Capitalization Scale $3.6B $6.1B Larger Scale MIRM
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +39.6% Higher Growth MIRM
Operating Margin (TTM) Profitability 0.0% -21.6% Higher Margin ELVN
Net Profit Margin Profitability 0.0% -134.8% Higher Margin ELVN
Return on Equity (ROE) Capital Efficiency -16.8% -760.0% Higher ROE ELVN
52-Week Range Position Momentum 69% ($15โ€“$62) 44% ($63โ€“$130) Stronger Trend ELVN
Beta / 30D Volatility Risk Regime 0.96ฮฒ ยท 60% Vol 1.02ฮฒ ยท 49% Vol Lower Realized Risk MIRM
Unified Institutional Score Composite Signal 35.9 / 100 (SELL) 38.1 / 100 (SELL) Higher Composite MIRM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ELVN vs MIRM Buy Guide
ELVN CONSOLIDATION
59d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live ELVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MIRM BREAKDOWN
92d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live MIRM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ELVN nor MIRM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.